Denali Therapeutics  logo
Denali Therapeutics DNLI
$ 24.18 -1.0%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Denali Therapeutics EV/EBITDA Ratio 2011-2024 | DNLI

Annual EV/EBITDA Ratio Denali Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-14.1 84.8 -10.5 -43 -1.56 - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
84.8 -43 3.15